1,037
Views
6
CrossRef citations to date
0
Altmetric
Research Article

How the probability of presentation to a primary care clinician correlates with cancer survival rates: a European survey using vignettes

, , , , , , & show all
Pages 27-34 | Received 18 Mar 2016, Accepted 22 Sep 2016, Published online: 06 Mar 2017

References

  • Møller H, Linklater KM, Robinson D. A visual summary of the EUROCARE-4 results: a UK perspective. Br J Cancer. 2009;101:S110–S114.
  • Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2014;26:62038–62039.
  • Abdel-Rahman M, Stockton D, Rachet B, et al. What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer. 2009;101:S115–SS24.
  • Richards MA. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer. 2009;101:S125–S1S9.
  • Carter JL, Coletti RJ, Harris RP. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ. 2015;350:g7773.
  • Zahl PH, Jorgensen KJ, Gotzsche PC. Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis. Br J Cancer. 2013;109:2014–2019.
  • Woods LM, Coleman MP, Lawrence G, et al. Evidence against the proposition that “UK cancer survival statistics are misleading”: simulation study with national cancer registry data. BMJ. 2011;342:d3399.
  • EUROCARE (ed). EUROCARE-5. Milan IaISdSR, Italy: Istituto Nazionale Tumori; 2014.
  • Sant M. Differences in stage and therapy for breast cancer across Europe. Int J Cancer. 2001;93:894–901.
  • Sant M, Allemani C, Capocaccia R, et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer. 2003;106:416–422.
  • Imperatori A, Harrison RN, Leitch DN, et al. Lung cancer in Teesside (UK) and Varese (Italy): a comparison of management and survival. Thorax. 2006;61:232–239.
  • De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol. 2014;15:23–34.
  • Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the international cancer benchmarking partnership): an analysis of population-based cancer registry data. Lancet. 2011;377:127–138.
  • Vedsted P, Olesen F. Are the serious problems in cancer survival partly rooted in gatekeeper principles? Br J Gen Pract. 2011;61:3–512.
  • Foot C, Harrison T. How to improve cancer survival: explaining England’s relatively poor rates. London: The King’s Fund; 2011. p. 30.
  • Nielsen TN, Hansen RP, Vedsted P. Symptom presentation in cancer patients in general practice. Ugeskr Laeger. 2010;172:2827–2831.
  • Jones R, Latinovic R, Charlton J, et al. Alarm symptoms in early diagnosis of cancer in primary care: cohort study using general practice research database. BMJ. 2007;334:1040.
  • Harris M, Frey P, Esteva M, et al. How health system factors influence referral decisions in patients that may have cancer: European symposium report. J Cancer Res Ther. 2016;4:7–10.
  • Rose PW, Hamilton W, Aldersey K, et al. Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions. BMC Fam Pract. 2014;15:122.
  • Hamilton W. The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer. 2009;101 Suppl 2:S80–S86.
  • Hamilton W, Peters TJ, Bankhead C, et al. Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. BMJ. 2009;339:b2998.
  • Walker S, Hyde C, Hamilton W. Risk of breast cancer in symptomatic women in primary care: a case-control study using electronic records. Br J Gen Pract. 2014;64:e788–e793.
  • Murphy MK, Black NA, Lamping DL, et al. Consensus development methods, and their use in clinical guideline development. Health Technol Assess. 1998;2:i–iv.
  • National Cancer Intelligence Network. Routes to diagnosis 2006–2013, preliminary results. London: Public Health England; 2015.
  • Elliss-Brookes L, McPhail S, Ives A, et al. Routes to diagnosis for cancer–determining the patient journey using multiple routine data sets. Br J Cancer. 2012;107:1220–1226.
  • Kao AB, Couzin ID. Decision accuracy in complex environments is often maximized by small group sizes. Proc Biol Sci. 2014;281: 20133305.
  • Hare A. A study of interaction and consensus in different sized groups. Am Sociol Rev. 1952;17:261–267.
  • Kringos DS, Boerma W, van der Zee J, et al. Europe’s strong primary care systems are linked to better population health but also to higher health spending. Health Aff (Millwood). 2013;32:686–694.
  • Rose PW, Rubin G, Perera-Salazar R, et al. Explaining variation in cancer survival between 11 jurisdictions in the international cancer benchmarking partnership: a primary care vignette survey. BMJ Open. 2015;5:e007212.
  • Rubin G, Vedsted P, Emery J. Improving cancer outcomes: better access to diagnostics in primary care could be critical. Br J Gen Pract. 2011;61:317–318.
  • Brown S, Castelli M, Hunter D, et al. How might healthcare systems influence speed of cancer diagnosis: a narrative review. Soc Sci Med. 2014;116:56–63.
  • Andersen RS, Vedsted P, Olesen F, et al. Does the organizational structure of health care systems influence care-seeking decisions? A qualitative analysis of Danish cancer patients’ reflections on care-seeking. Scand J Prim Health Care. 2011;29:144–149.
  • Melling PP, Hatfield AC, Muers MF, et al. Lung cancer referral patterns in the former Yorkshire region of the UK. Br J Cancer. 2002;86:36–42.
  • Ades AE, Biswas M, Welton NJ, et al. Symptom lead time distribution in lung cancer: natural history and prospects for early diagnosis. Int J Epidemiol. 2014;43:1865–1873.
  • Jack RH, Gulliford MC, Ferguson J, et al. Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services? Br J Cancer. 2003;88:1025–1031.
  • Nicholson BD, Mant D, Neal RD, et al. International variation in adherence to referral guidelines for suspected cancer: a secondary analysis of survey data. Br J Gen Pract. 2016;66:e106–e113.
  • Dury C, Hall C, Danan JL, et al. Specialist nurse in Europe: education, regulation and role. Int Nurs Rev. 2014;61:454–462.
  • Read C. Time for some advanced thinking? The benefits of specialist nurses. Health Serv J 2015 (Suppl.)3–4.
  • McPhail S, Elliss-Brookes L, Shelton J, et al. Emergency presentation of cancer and short-term mortality. Br J Cancer. 2013;109:2027–2034.
  • Parekh R, Wilson-Theaker W, Sibanda V, et al. Demography and survival in lung cancer patients presenting to the accident and emergency department. Eur Respir J 2014;44: P2738.
  • Padgett DK, Brodsky B. Psychosocial factors influencing non-urgent use of the emergency room: a review of the literature and recommendations for research and improved service delivery. Soc Sci Med. 1992;35:1189–1197.
  • Thoresen CK, Sandvik H, Hunskaar S. Cancer patients’ use of primary care out-of-hours services: a cross-sectional study in Norway. Scand J Prim Health Care. 2016;34:232–239.